Overview
- 2 inspections across 2 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-08-08.
At a glance
Inspections
2
Sites
2
Observations
0
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| BioReliance Corporation | 8 Aug 2019 | Human Drugs | On file |
| AstraZeneca Pharmaceuticals LP | 20 Sep 2017 | Human Drugs |
Sites inspected
BioReliance CorporationRockville, United States1 insp.
AstraZeneca Pharmaceuticals LPGaithersburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Charles R Bonapace's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site